Braskem stock falls as UBS cuts ADR rating to Sell and slashes target

Braskem S.A. stock (ISIN US10554K1025) extended its recent slide after the New York-listed ADR fell about 15 percent to roughly USD 1.77 on September 16, 2026, following a high-profile downgrade by UBS that sharply cut its price target to USD 1.50 from USD 4.00.

UBS downgrade intensifies pressure

According to Seeking Alpha on September 16, 2026, UBS downgraded Braskem’s New York ADR from Neutral to Sell and reduced its price target to USD 1.50 from USD 4.00, citing persistent pressure on petrochemical spreads and the complexity of the company’s restructuring efforts.

The impact on the share price was immediate: the ADR dropped around 15.2 percent in that session, reflecting investors’ concern about leverage, restructuring risk and a challenged earnings outlook, as highlighted by GuruFocus on September 16, 2026.

Short interest and recent trading metrics

As of a short-interest update dated September 16, 2026, shares of Braskem’s ADR on the New York Stock Exchange traded down USD 0.34 intraday to USD 1.76, with 2,604,219 shares changing hands compared with average volume of 2,416,358, according to MarketBeat.

The same overview noted that Braskem’s ADR had a 12-month low of USD 1.40 and a 12-month high of USD 5.39, placing the USD 1.76 level roughly 25 percent above the low and around 67 percent below the high, with the stock trading well below its 50-day moving average of USD 2.16 and 200-day moving average of USD 3.24.

MarketBeat also reported that short interest in Braskem surged 77 percent between August 15 and August 31, 2026, reaching 6.06 million shares, equivalent to about 1.5 percent of shares outstanding, and resulting in a short-interest ratio of 1.6 days based on average daily volume.

Analyst sentiment turns strongly bearish

According to the same short-interest review by MarketBeat on September 16, 2026, analyst sentiment on Braskem has turned strongly bearish, with houses including JPMorgan, UBS and Citigroup having downgraded the stock and UBS cutting its ADR price target to USD 1.50.

The same source stated that the consensus rating stands at Strong Sell, with an average target price of USD 2.83, implying upside of roughly 60 percent from the USD 1.76 trading level but against a backdrop of negative net margin of 7.28 percent and negative return on equity of 67.75 percent reported in recent results.

In its valuation-focused analysis on September 16, 2026, GuruFocus calculated Braskem’s price-to-sales ratio at about 0.13 based on the current ADR price, significantly below its historical median P/S of around 0.30 and below typical industry levels, and estimated that the shares trade around 65.7 percent below a proprietary GF Value indication of USD 5.21 per ADR.

Debt restructuring and fundamental backdrop

Beyond the immediate price reaction, the downgrade comes in the context of a deep restructuring effort. As Valor International reported on September 17, 2026, Braskem filed for an out-of-court restructuring on August 24, 2026, seeking to restructure about BRL 56.5 billion in financial debt, with initial support from creditors representing 39.6 percent of the liabilities covered by the process.

According to Valor International on September 17, 2026, the company’s situation is described as more severe than that of most global petrochemical peers, reflecting a combination of pressured spreads, past environmental liabilities in Maceio, operational challenges in Mexico and the ongoing search for a sustainable capital structure.

While detailed quarterly revenue and EBITDA figures for 2026 are not fully laid out in these week-filtered sources, the negative net margin of 7.28 percent and negative return on equity of 67.75 percent reported in the MarketBeat overview for the latest twelve-month period underline that the company has been loss-making, with earnings pressure limiting the usefulness of traditional price-to-earnings metrics.

Local share move and creditor negotiations

The downgrade by UBS also hit Braskem’s Brazilian-listed preferred shares. As The Rio Times reported on September 17, 2026, the preferred shares closed at BRL 4.53 on September 16, 2026, down 15.16 percent from BRL 5.34 in the previous session, while the New York ADR fell around 15.71 percent to approximately USD 1.77.

Further Brazilian coverage from Bahia Economica on September 16, 2026 highlighted UBS BB’s cut of the local share price target to BRL 3.75 from BRL 10.50 and pointed to the perceived risk of shareholder dilution through a potential conversion of debt into equity as part of the restructuring.

Meanwhile, a pre-open summary from The Rio Times dated September 17, 2026 noted that Braskem’s Brazilian shares fell 15.2 percent with turnover of about BRL 57 million and reminded that the company had left the Ibovespa index in August after filing for out-of-court restructuring, meaning the sharp decline no longer directly affects that benchmark.

Investor perspective and current price level

For investors tracking Braskem stock, the New York ADR’s recent level around USD 1.76 to USD 1.77 as of mid-September 2026 stands close to its 12-month low of USD 1.40 and well below the 12-month high of USD 5.39, underscoring how the combination of heavy leverage, restructuring uncertainty, weak petrochemical spreads and bearish analyst revisions has compressed the valuation.

More news and analyses on Braskem S.A. stock